No Association Between MTHFR A1298C Gene Polymorphism and Head and Neck Cancer Risk: A Meta-analysis Based on 9,952 Subjects |
Niu, Yu-Ming
(Department of Stomatology, Taihe Hospital, Hubei University of Medicine)
Shen, Ming (Institute of Stomatology, Nanjing Medical University) Li, Hui (Department of Stomatology, the First Hospital of Huainan) Ni, Xiao-Bing (Department of Stomatology, Taihe Hospital, Hubei University of Medicine) Zhou, Juan (Department of Stomatology, Taihe Hospital, Hubei University of Medicine) Zeng, Xian-Tao (Department of Stomatology, Taihe Hospital, Hubei University of Medicine) Leng, Wei-Dong (Department of Stomatology, Taihe Hospital, Hubei University of Medicine) Wu, Ming-Yue (School of Stomatology, Anhui Medical University) |
1 | Argiris A, Karamouzis MV, Raben D, et al (2008). Head and neck cancer. Lancet, 371, 1695-709. DOI |
2 | Blount BC, Mack MM, Wehr CM, et al (1997). Folate deficiency causes uracil misincorporation into human DNA and chromosome breakage: implications for cancer and neuronal damage. Proc Natl Acad Sci USA, 94, 3290-5. DOI ScienceOn |
3 | Cao Y, Miao XP, Huang MY, et al (2010). Polymorphisms of methylenetetrahydrofolate reductase are associated with a high risk of nasopharyngeal carcinoma in a smoking population from Southern China. Mol Carcinog, 49, 928-34. DOI |
4 | Capaccio P, Ottaviani F, Cuccarini V, et al (2005). Association between methylenetetrahydrofolate reductase polymorphisms, alcohol intake and oropharyngolaryngeal carcinoma in northern Italy. J Laryngol Otol, 119, 371-6. |
5 | DerSimonian R, Laird N (1986). Meta-analysis in clinical trials. Control Clin Trials, 7, 177-88. DOI |
6 | Galbiatti AL, Ruiz MT, Rodrigues JO, et al (2012). Polymorphisms and haplotypes in methylenetetrahydrofolate reductase gene and head and neck squamous cell carcinoma risk. Mol Biol Rep, 39, 635-43. DOI |
7 | Harbord RM, Egger M, Sterne JA (2006). A modified test for small-study effects in meta-analyses of controlled trials with binary endpoints. Stat Med, 25, 3443-57. DOI |
8 | Hung RJ, Hashibe M, McKay J, et al (2007). Folate-related genes and the risk of tobacco-related cancers in Central Europe. Carcinogenesis, 28, 1334-40. DOI ScienceOn |
9 | Jemal A, Bray F, Center MM, et al (2011). Global cancer statistics. CA Cancer J Clin, 61, 69-90. DOI |
10 | Kawakami K, Ruszkiewicz A, Bennett G, et al (2003). The folate pool in colorectal cancers is associated with DNA hypermethylation and with a polymorphism in methylenetetrahydrofolate reductase. Clin Cancer Res, 9, 5860-5. |
11 | Kim YI (1999). Folate and carcinogenesis: evidence, mechanisms, and implications. J Nutr Biochem, 10, 66-88. DOI ScienceOn |
12 | Kim YI (1999). Folate and cancer prevention: a new medical application of folate beyond hyperhomocysteinemia and neural tube defects. Nutr Rev, 57, 314-21. |
13 | Kruszyna L, Lianeri M, Rydzanicz M, et al (2010). Polymorphic variants of folate metabolism genes and the risk of laryngeal cancer. Mol Biol Rep, 37, 241-7. DOI |
14 | Mantel N, Haenszel W (1959). Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst, 22, 719-48. |
15 | Lau J, Ioannidis JP, Schmid CH (1997). Quantitative synthesis in systematic reviews. Ann Intern Med, 127, 820-6. DOI ScienceOn |
16 | Lievers KJ, Boers GH, Verhoef P, et al (2001). A second common variant in the methylenetetrahydrofolate reductase (MTHFR) gene and its relationship to MTHFR enzyme activity, homocysteine, and cardiovascular disease risk. J Mol Med (Berl), 79, 522-8. DOI |
17 | Little J, Bradley L, Bray MS, et al (2002). Reporting, appraising, and integrating data on genotype prevalence and genedisease associations. Am J Epidemiol, 156, 300-10. DOI |
18 | Neumann AS, Lyons HJ, Shen H, et al (2005). Methylenetetrahydrofolate reductase polymorphisms and risk of squamous cell carcinoma of the head and neck: a case-control analysis. Int J Cancer, 115, 131-6. DOI |
19 | Ni X, Tai J, Ma LJ, et al (2008). [Association between genetic polymorphisms in methylenetetrahydrofolate reductase and risk of laryngeal squamous cell carcinoma]. Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi, 43, 435-8. |
20 | Parle-McDermott A, Mills JL, Molloy AM, et al (2006). The MTHFR 1298CC and 677TT genotypes have opposite associations with red cell folate levels. Mol Genet Metab, 88, 290-4. DOI |
21 | Ragin CC, Modugno F, Gollin SM (2007). The epidemiology and risk factors of head and neck cancer: a focus on human papillomavirus. J Dent Res, 86, 104-14. DOI |
22 | Sailasree R, Nalinakumari KR, Sebastian P, et al (2011). Influence of methylenetetrahydrofolate reductase polymorphisms in oral cancer patients. J Oral Pathol Med, 40, 61-6. DOI |
23 | van der Put NM, Gabreels F, Stevens EM, et al (1998). A second common mutation in the methylenetetrahydrofolate reductase gene: an additional risk factor for neural-tube defects? Am J Hum Genet, 62, 1044-51. DOI ScienceOn |
24 | Stern LL, Mason JB, Selhub J, et al (2000). Genomic DNA hypomethylation, a characteristic of most cancers, is present in peripheral leukocytes of individuals who are homozygous for the C677T polymorphism in the methylenetetrahydrofolate reductase gene. Cancer Epidemiol Biomarkers Prev, 9, 849-53. |
25 | Suzuki T, Matsuo K, Hasegawa Y, et al (2007). One-carbon metabolism-related gene polymorphisms and risk of head and neck squamous cell carcinoma: case-control study. Cancer Sci, 98, 1439-46. DOI |
26 | Tsai CW, Hsu CF, Tsai MH, et al (2011). Methylenetetrahydrofolate reductase (MTHFR) genotype, smoking habit, metastasis and oral cancer in Taiwan. Anticancer Res, 31, 2395-9. |
27 | Weisberg I, Tran P, Christensen B, et al (1998). A second genetic polymorphism in methylenetetrahydrofolate reductase (MTHFR) associated with decreased enzyme activity. Mol Genet Metab, 64, 169-72. DOI ScienceOn |
28 | Weisberg IS, Jacques PF, Selhub J, et al (2001). The 1298A-- >C polymorphism in methylenetetrahydrofolate reductase (MTHFR): in vitro expression and association with homocysteine. Atherosclerosis, 156, 409-15. DOI |